| Literature DB >> 30333321 |
Hakan Cangul1, Xiao-Hui Liao2, Erik Schoenmakers3, Jukka Kero4,5, Sharon Barone6, Panudda Srichomkwun2, Hideyuki Iwayama2, Eva G Serra7, Halil Saglam8, Erdal Eren8, Omer Tarim8, Adeline K Nicholas3, Ilona Zvetkova3, Carl A Anderson7, Fiona E Karet Frankl9, Kristien Boelaert10, Marja Ojaniemi11, Jarmo Jääskeläinen12, Konrad Patyra4, Christoffer Löf4, E Dillwyn Williams13, Manoocher Soleimani6, Timothy Barrett14, Eamonn R Maher15, V Krishna Chatterjee3, Samuel Refetoff2,16, Nadia Schoenmakers3.
Abstract
Defects in genes mediating thyroid hormone biosynthesis result in dyshormonogenic congenital hypothyroidism (CH). Here, we report homozygous truncating mutations in SLC26A7 in 6 unrelated families with goitrous CH and show that goitrous hypothyroidism also occurs in Slc26a7-null mice. In both species, the gene is expressed predominantly in the thyroid gland, and loss of function is associated with impaired availability of iodine for thyroid hormone synthesis, partially corrected in mice by iodine supplementation. SLC26A7 is a member of the same transporter family as SLC26A4 (pendrin), an anion exchanger with affinity for iodide and chloride (among others), whose gene mutations cause congenital deafness and dyshormonogenic goiter. However, in contrast to pendrin, SLC26A7 does not mediate cellular iodide efflux and hearing in affected individuals is normal. We delineate a hitherto unrecognized role for SLC26A7 in thyroid hormone biosynthesis, for which the mechanism remains unclear.Entities:
Keywords: Endocrinology; Genetics; Molecular genetics; Monogenic diseases; Thyroid disease
Mesh:
Substances:
Year: 2018 PMID: 30333321 PMCID: PMC6237461 DOI: 10.1172/jci.insight.99631
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708